The EPIC-InterAct study: a study of the interplay between genetic and lifestyle behavioural factors on the risk of type 2 diabetes in European populations by Forouhi, Nita & Wareham, Nicholas
PUBLIC HEALTH AND TRANSLATIONAL MEDICINE (PW FRANKS, SECTION EDITOR)
The EPIC-InterAct Study: A Study of the Interplay
between Genetic and Lifestyle Behavioral Factors on the Risk
of Type 2 Diabetes in European Populations
Nita G. Forouhi & Nicholas J. Wareham
Published online: 11 October 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract The rising prevalence of type 2 diabetes around the
world and the global pattern of variation in risk between
countries have been widely attributed to an interplay between
rising rates of obesity and poor lifestyles, and genetic or
developmental susceptibility to disease. Although this general
hypothesis has been in existence for more than 50 years, the
precise mechanisms that may explain it have remained uncer-
tain. Advances in technology and the application of new
methods in large scale population studies have made it possi-
ble to study these mechanisms. The InterAct project, funded
by the European Commission, is a large case-cohort study
which has verified 12,403 incident cases of type 2 diabetes,
facilitating the study of genetic and lifestyle factors on the risk
of type 2 diabetes among European populations.
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Introduction
Type 2 diabetes is a major contemporary public health issue
because of its high and rising prevalence worldwide and its
association with diverse complications that lead to premature
morbidity and mortality. The cost of the disease to individuals,
carers, health systems, and society is considerable. The latest
estimates from the International Diabetes Federation suggest
that 382 million people had diabetes in 2013, and that this
prevalence is projected to increase to 592million by 2035 [1•].
Several randomised controlled trials have provided strong
evidence that the primary prevention of type 2 diabetes is
possible through lifestyle interventions aimed at changing diet
and physical activity [2–6]. However, many uncertainties
remain about how to translate this potential into action in
real-world settings. Firstly, it is unclear how to determine the
appropriate balance between investment in approaches to
prevention that focus on individuals at high risk of diabetes
as opposed to efforts that seek to impact on the entire popu-
lation. Secondly, where high risk approaches are proposed, it
is unclear whether detailed assessment of individual suscepti-
bility to diabetes through estimation of genetic risk, for exam-
ple, plays a role in identifying people who may benefit from
individualised prevention. Finally there are uncertainties
about the details of the nutritional and dietary guidelines that
should form the basis of public health targets as opposed to
recommendations for change among individuals at high risk.
When the World Health Organization reviewed the evidence
for the association between diet and the development of type 2
diabetes a decade ago, no dietary factor fulfilled the criteria to
qualify for convincing grade evidence [7]. Progress has been
made since then with evidence arising predominantly from
US-based cohorts, but systematic, large-scale evidence from
Europe-based populations was still unavailable.Moreover, the
investigation of an interaction between genetic and lifestyle
factors has been a challenge as this would require an ade-
quately powered study with a large sample size, availability of
genetic data as well as robustly collected valid data on lifestyle
factors.
To address these research gaps, the InterAct project (http://
www.inter-act.eu) was funded by the European Union (EU)
within its FP6 framework to investigate the interaction of
genes and lifestyle on the risk of type 2 diabetes. A feature
of this study that made it suitable for this purpose was that it
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was embedded in a multi-country cohort study (The EPIC
study) with heterogeneity of dietary exposures which were
assessed within a standardised framework. The initial study
was very large and with sufficient elapsed time so that Inter-
Act was able to accrue four million person-years of follow-up
and ascertain and verify 12,403 incident cases of type 2
diabetes. Previous studies on gene-lifestyle interaction have
demonstrated the importance of correctly parameterising and
characterising the main lifestyle exposures before proceeding
to investigate interaction [8]. Therefore, a key initial stage in
InterAct was the examination of the nature and magnitude of
the relationship between a variety of lifestyle behavioural
factors and incident diabetes. Not only did this process set
the stage for the examination of interaction, but it is also of
public health importance in its own right as it guides the
design of public health interventions.
The InterAct Project
The InterAct project is co-ordinated by the Medical Research
Council Epidemiology Unit, Cambridge, and it is largely
centred on constructing a nested case-cohort study within
eight of the ten participating countries of the European Pro-
spective Investigation into Cancer (EPIC) cohort study:
France, Italy, Spain, UK, the Netherlands, Germany, Sweden,
and Denmark. Collaborators in 26 European research centres
ascertained and verified 12,403 cases of incident type 2 dia-
betes from a total cohort of 340,234 people with four million
person-years of follow-up, and randomly selected 16,835
subcohort participants from the full cohort [9••]. After exclu-
sions, a representative subcohort of 16,154 individuals
remained. A design feature of the case-cohort design is that
due to the process of random selection, a number of future
disease cases are also included within the subcohort. Thus, the
total sample of EPIC-InterAct included 12,403 case partici-
pants with type 2 diabetes, and 16,154 subcohort participants,
of whom 778 formed an overlap group between the case-
group and the subcohort group as they had incident type 2
diabetes during follow-up. The case-cohort design should be
thought of as a subcohort study with additional incident cases
added rather than as a case-control study. The statistical anal-
ysis for the case-cohort design accounts for the small number
of cases in the subcohort. Incident type 2 diabetes cases were
ascertained up until 31 December 2007 through a review of
several sources of evidence including self-report, linkage to
primary care registers, secondary care registers, medication
use, hospital admissions and mortality data. No diabetes cases
were ascertained solely by self-report, but rather confirmatory
evidence was sought for all cases with information about
incident type 2 diabetes with fewer than two independent
sources, including a review of individual medical records in
some centres [9••].
The Association Between Diet, Nutrition, and the Risk
of Type 2 Diabetes
Detailed self-report assessments of food intake were made in
each participating centre using validated country-specific die-
tary questionnaires, mostly food frequency questionnaires
(FFQ). A bespoke European nutrient database was used
[10]. Comprehensive approaches to analysis were taken, in-
cluding adjustment for energy intake, statistical models that
included the residual method where relevant, measurement
error correction using calibration of FFQ data against the 24-h
recall in a subset of the sample, and adjustment for a range of
potential confounding factors including known diabetes risk
factors, demographic, social, lifestyle and dietary factors.
Food Groups and the Development of Type 2 Diabetes
The publication of three meta-analyses had indicated a posi-
tive association between a diet rich in red and processed meat
consumption and the risk of type 2 diabetes [11–13], with a
focus largely on US-based studies. Though individual studies
investigating this had started emerging from Europe [14–16],
there remained a lack of a systematic approach and adequate
sample size. EPIC-InterAct reported that across eight Europe-
an countries, for every 50-g increase in consumption of red
meat and processedmeat, there was a higher risk of future type
2 diabetes, with a hazard ratio (HR) of 1.08 [95 % confidence
interval (CI) 1.03, 1.13] and 1.12 (95 %CI: 1.05, 1.19),
respectively, independent of a comprehensive range of poten-
tial confounding factors [17].
In contrast to the more consistent findings for meat intake
and diabetes risk, there were previously inconclusive findings
for the association between the consumption of dairy products
and diabetes risk, in particular for dairy sub-types [18]. There
was a general paucity of such research in Europe, which was
surprising given that Europe has the highest intake of dairy
products in the world [19]. A previous analysis in the EPIC
study had shown substantial variation in the amount of total
and types of dairy products consumed across Europe, with
high cheese consumption in France and high yoghurt con-
sumption in Sweden and the Netherlands [20]. With its vary-
ing dairy products intake, the EPIC-InterAct study reported
that intake of total dairy products, or of milk, was not related
to future diabetes risk, but the consumption of combined
fermented dairy products (yoghurt; cheese; thick fermented
milk) was associated with a reduced risk of incident diabetes
(HR 0.88, 95 % CI 0.78, 0.99) [21].
Evidence on the role of fish intake for diabetes risk has
been conflicting, ranging from proposed beneficial [22] to
harmful [23, 24] to null effects [25]. Findings from the
EPIC-InterAct study have indicated that only sub-types of
fish intake, rather than total fish intake, may be related to
diabetes risk [26]. Further to the InterAct findings, evidence
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is accumulating that geographic location plays an important
role in the nature of the association between fish intake and
diabetes risk [25, 27•].
Fruit and vegetable intake is a recommended component of a
healthy diet, but little evidence was available generally, and
particularly from Europe, for a link between intake and diabetes
risk [28]. We conducted a systematic review of previously
published literature and then performed a meta-analysis along
with new data from EPIC-InterAct. Our analysis of 179,956
participants and 19,123 incident type 2 diabetes cases reported
that those consuming the highest fruit and vegetable intake had
a 7 % (95 % CI: 0.87 – 1.00) lower risk of diabetes when
compared with the lowest intake consumers, with a particular
benefit for consumption of green leafy vegetables [29]. This
work has providedmore convincing evidence for the benefits of
fruit and vegetable consumption for the prevention of diabetes.
Beverages and the Development of Type 2 Diabetes
There has been increasing interest in associations between the
consumption of sweetened beverages and the risk of develop-
ing diabetes, but data from Europe had been sparse, with only
one European country (Finland) contributing to a systematic
review and meta-analysis [30•]. EPIC-InterAct investigated
associations between both sugar-sweetened beverage (SSB)
and artificially sweetened beverage (ASB) intake and the
development of incident type 2 diabetes [31•]. In adjusted
analyses, EPIC-InterAct reported a multivariable-adjusted
22 % (95 % CI: 9 % to 38 %) higher incidence of type 2
diabetes for every one serving/day (336 g standard size can of
drink) of greater habitual consumption of SSB. A previous
meta-analysis was unable to distinguish associations with and
without adjustment for obesity [32], but in EPIC-InterAct there
was a persisting 18 % higher incidence of diabetes (95 % CI:
6 % to 32 %) even after adjustment for adiposity. Though there
was a positive association between habitual ASB consumption
and diabetes risk, the association became non-significant after
accounting for baseline obesity (body mass index); HR of 1.11
(95 % CI: 0.95, 1.31) for every one serving greater habitual
consumption of ASB, in adjusted analyses including adjust-
ment for energy intake and body mass index [31•].
EPIC-InterAct also reported that greater tea consumption
was associated with a lower risk of type 2 diabetes among
Europeans. Individuals who reported drinking at least four
cups of tea per day had a 16 % (95 % CI: 0.71 – 1.00) lower
risk of developing type 2 diabetes compared to those who
reported no tea consumption [33].
Dietary Patterns and the Development of Type 2 Diabetes
There has been increasing recognition that people consume
overall diets within certain patterns which are largely healthy
or unhealthy [34]. Therefore, it is of interest to study the
association of dietary patterns with health, in addition to the
associations of individual food groups and foods. In the first
large-scale study, EPIC-InterAct has reported that people who
ate a dietary pattern in concordance with the principles of the
Mediterranean diet had a reduced risk of developing diabetes
[35]. The InterAct Consortium further extended its enquiry to
include other predefined dietary patterns and also applied
reduced rank regression (RRR) as a mixture of a hypothesis-
oriented and an exploratory approach that is aimed at identi-
fying food group combinations that explain a maximum of
variation in (disease-related) response variables [36]. In EPIC-
InterAct there was no association between the alternative
Healthy Eating Index (aHEI) and the Dietary Approaches to
Stop Hypertension (DASH) score and diabetes risk, but in-
verse associations were observed for three RRR-derived die-
tary pattern scores [37]. The study confirmed that adherence to
specific dietary patterns, commonly characterised by high
intake of fruits or vegetables and low intake of processed
meat, sugar-sweetened beverages, and refined grains, may
lower type 2 diabetes risk.
Nutrients, Nutritional Compounds, and the Development
of Type 2 Diabetes
Past research on the association between protein intake and
risk of diabetes included the limitations of small sample size
or cross-sectional evidence [38, 39], lack of investigation of
type of protein (animal or plant origin) [40] or lack of associ-
ation in obesity-adjusted analyses [41]. In EPIC-InterAct the
incidence of type 2 diabetes was higher in those with the
highest intake of total protein [per 10 g: HR: 1.06 (95 % CI:
1.02, 1.09), p-trend<0.001] and animal protein [per 10 g: HR:
1.05 (1.02, 1.08), p-trend=0.001], but in contrast, intake of
plant protein was not associated with type 2 diabetes [per 10 g:
HR: 1.04 (95 % CI: 0.93, 1.16), p-trend=0.098] [42], after
adjustment for known confounders. These findings are con-
sistent with advice to limit diets high in dietary proteins,
particularly from animal sources.
EPIC-InterAct also investigated carbohydrates intake, to-
gether with their glycaemic properties, as expressed by the
glycaemic index (GI) and the glycaemic load (GL), and found
no association with diabetes risk [43]. This is in contrast to
findings from three meta-analyses of prospective, predomi-
nantly American studies, published prior to InterAct findings,
that reported increased diabetes risk in the highest GI and GL
categories, ranging from an increased risk of 16 % (GI) and
20 % (GL) to 58 % (both GI and GL) [44–46]. Further reports
of a positive association between both GI and GL and risk of
incident type 2 diabetes subsequent to the publication of
findings from InterAct are also at variance with the null
InterAct finding [47]. The investigation of GI values across
different countries or even within the same population (such
as one of the participating cohorts in InterAct) highlighted an
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important issue that an expansion of GI tables and systematic
GI value assignment to foods is needed to improve the validity
of GI values in cross-study comparisons. Analyses on the
association between fibre intake and diabetes risk are com-
plete in InterAct, and will be published combined with an
updated systematic review and meta-analysis in the near
future.
EPIC-InterAct found no association between dietary ener-
gy density of solid and semi-solid foods and incident type 2
diabetes [48]. This work highlighted the complexities of con-
sensus on how energy density should be calculated, the po-
tential role of under- or over-reporting, and the challenges of
teasing out direct (on T2D) versus indirect (on obesity, weight
gain) effects of dietary energy density, but concluded that
energy density was likely to have only a small influence on
the development of T2D even if these complexities were
overcome.
There has been interest in the potential effects of flavo-
noids, a group of nutritional compounds of the polyphenol
family that are contained in plant-based foods such as fruits,
vegetables, nuts, legumes, cocoa, some cereals, and in tea,
wine, and juice, but past evidence has been inconclusive for
association with diabetes [49–54]. EPIC-InterAct reported
that total flavonoid intake tended towards an inverse associa-
tion with incident diabetes (HR 0.90, 0.77, 1.04, p-trend=
0.04), but higher and stronger significant inverse associations
were found for flavonoid sub-classes [55]. In particular, the
HR when comparing the top quintile versus the bottom quin-
tile of intake of flavonols were 0.81 (0.69, 0.95), and flavanols
0.82 (0.68, 0.99), including flavan-3-monomers 0.73 (0.57,
0.93) demonstrated an association with reduced incident dia-
betes. Further inspection of individual flavonoids (beyond
classes of flavonoids) highlighted significant inverse trends
between intakes of all individual flavan-3-ol monomers and
diabetes incidence [56]. Additionally, proanthocyanidin di-
mers and trimers, but not proanthocyanidins with a greater
degree of polymerisation were inversely associated. Among
the flavonol sub-class, myricetin (HR 0.77, 0.64, 0.93) was
associated with a lower incidence of T2D. Our findings pro-
vided the first comprehensive examination of both flavonoid
classes and individual flavonoids, using a comprehensive
flavonoid food composition database that was developed
using both the Phenol-Explorer (the U.K. Food Standards
Agency) and the U.S. Department of Agriculture databases
[55]. These findings provide meaningful contributions toward
our understanding of how a dietary pattern rich in plant-based
foods helps with the prevention of type 2 diabetes.
In the context of strong epidemiological evidence that
circulating concentrations of 25-hydroxy vitamin D
[25(OH)D] are related inversely to the development of type
2 diabetes [57], EPIC-InterAct also appraised the role of
dietary vitamin D, as a contributing source of circulating
25(OH)D levels. The study reported a null association
between vitamin D intake and risk of diabetes in both the total
and sex-specific analyses. This should be interpreted in light
of the relatively greater contribution of endogenous synthesis
of 25(OH)D following sunlight exposure, and thus the evi-
dence from our large-scale study confirming no association of
type 2 diabetes with dietary vitamin D intake provides impor-
tant information in helping to distinguish between dietary and
endogenously synthesised vitamin D.
Moving Beyond Self-Report Assessment of Diet to Using
Nutritional Biomarkers
To overcome the well-acknowledged limitation of measure-
ment error in nutritional epidemiology, InterAct has invested
substantial effort into generating evidence on blood-based
objective biomarkers that reflect nutritional intake.
There has been little comprehensive assessment of objec-
tively measured circulating fatty acids in relation to diabetes
risk across the range of individual fatty acids of varying
carbon chain lengths. Reasons include the expense of mea-
surement and the challenge of measuring them in large studies
due to the substantial laboratory run-time and personnel time
needed to process fatty acids on a large scale. In a collabora-
tion between analytical chemists and epidemiologists, Inter-
Act undertook to establish a high throughput method to mea-
sure 37 fatty acids in the plasma phospholipid fraction at the
MRC Human Nutrition Research, Cambridge [58]. This en-
abled the measurement of plasma phospholipid fatty acids on
an unprecedented scale, allowing the measurement of nearly
28,000 EPIC-InterAct samples.
In analyses focused on nine individual saturated fatty acids
(SFAs), there were opposite directions of association with
diabetes with SFA of varying carbon chain lengths [59•]. As
shown in Fig. 1, odd-chain SFAs were associated inversely
with incident diabetes [HR (95%CI) per 1 SDdifference for 15:0
(pentadecanoic acid) 0.79 (0.73, 0.85), and for 17:0
(heptadecanoic acid) 0.67 (0.67, 0.71)], while even-
chain SFAs were positively associated [14:0 (myristic acid)
HR 1.15 (1.09, 1.22), 16:0 (palmitic acid) HR 1.26
(1.15,1.37), and 18:0 (stearic acid) 1.06 (1.00, 1.13)]. The
very-long chain SFA (number of carbon atoms in chains
varying between 20 and 24) were associated with lower
diabetes incidence (HR ranging between 0.72 and 0.81 per 1
SD difference). The findings for odd-chain SFA can be under-
stood in terms of their exogenous source from dairy fat
[60–62] as well as the positive correlations in EPIC-InterAct
between dairy products and the sum of pentadecanoic (15:0)
and heptadecanoic (17:0) acids. This is in line with recent
work, including from EPIC-InterAct, indicating that dairy
products consumption is associated with lower risk of diabetes
[18, 21, 63•]. The findings for even-chain SFA are more
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complex as these SFA appear to be mainly derived from
hepatic endogenous synthesis (de novo lipogenesis), stimulated
by intakes of carbohydrates and alcohol as shown in
experimental studies [62, 64–67], and confirmed to some
degree by InterAct findings: stronger correlations of even-
chain SFA with intakes of potatoes, soft drinks, and alcohol
than with direct dietary sources such as meat or dairy. Very little
is currently known about the very-long chain SFA, and
EPIC-InterAct provides impetus for further investigation of
this group of SFA.
Taken together, EPIC-InterAct findings indicate that SFAs
are not a single homogenous group, and recognise differences
between the differential health effects of subtypes of blood
SFAs. The implication of this research is that it recognises that
it may not be enough to provide public health messages about
overall saturated fat intake, but that more nuanced messages
acknowledging the food sources of different types of SFAs are
required.
The biomarkers plasma vitamin C [68], 25-hydroxy
vitamin D [57], and carotenoids are currently being mea-
sured in stored samples from EPIC-InterAct participants.
The availability of a broad range of nutritional bio-
markers in EPIC-InterAct will open up possibilities for
more robust testing of causality of proposed diet-diabetes
associations using genetic Mendelian randomisation ex-
periments [69, 70].
Fig. 1 Hazard ratios and 95 % CIs for associations between plasma
phospholipid saturated fatty acids and incident type 2 diabetes in EPIC-
InterAct. Associations per 1 SD difference in (A) even-chain fatty acids
(saturated fatty acid [SFA] group 1: the sum of 14:0, 16:0, and 18:0), (B)
odd-chain fatty acids (SFA group 2: the sum of 15:0 and 17:0), and (C)
long- and very-long-chain fatty acids (SFA group 3: the sum of 20:0,
22:0, 23:0, and 24:0) and type 2 diabetes. Estimates are per country and
the pooled estimate is based on random-effects meta-analysis. The anal-
yses included 12 132 cases of type 2 diabetes and 15 919 people in the
subcohort (including 755 individuals with type 2 diabetes in the
subcohort); used age as the underlying time variable; and were adjusted
for centre, sex, smoking status, alcohol intake, physical activity, education
level, total energy intake, and BMI. Reproduced from Forouhi NG,
Koulman A, Sharp SJ, et al. Differences in the prospective association
between individual plasma phospholipid saturated fatty acids and incident
type 2 diabetes: the EPIC-InterAct case-cohort study. The Lancet Diabe-
tes & Endocrinology. 2014; pii: S2213-8587(14)70146-9, with permis-
sion from Elsevier
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The Association Between Physical Activity and the Risk
of Type 2 Diabetes
The physical activity questionnaire used in EPIC-Europe is
relatively simple and includes questions that quantify physical
activity at work and in recreation. Whilst originally it was
intended that analysis could use the concepts of duration,
intensity, and frequency of activities to provide a quantitative
summary of total activity, initial research demonstrated that
quantification was not valid [71]. This analysis also suggested
that an ordered categorical variable that created a global index
of physical activity for individuals without the attribution of
specific estimates of energy expenditure was valid and repeat-
able. Subsequent work demonstrated that this index predicted
other clinical endpoints such as cardiovascular disease, in-
creasing its face validity. Within InterAct, a cross-country
validation study was undertaken showing the validity of this
four category summary index of activity in all 10 countries in
EPIC [72]. In addition to demonstrating overall validity, this
analysis also quantified the energy expenditure difference
between physical activity categories, suggesting that each
category difference was equivalent to a difference in physical
activity energy expenditure of 380 – 460 kJ per day or 20 min
of brisk walking. InterAct then went on to quantify the rela-
tionship between this summary index of activity and the
incidence of diabetes, showing that for each category differ-
ence in the physical activity index, there was a 13% reduction
in risk of type 2 diabetes in men and 7% in women [73•]. This
quantification of the dose-response relationship is of value in
guiding expectations about what can be achieved through
small changes in population-level physical activity.
Interaction Between Genes and Lifestyle Factors
on the Risk of Type 2 Diabetes
Through the studies described above, InterAct has, therefore,
robustly characterised the relationship between the main life-
style exposures and diabetes, which not only guides public
health interventions, but also provides a platform for investi-
gating how those associations are modified by genetic and
developmental susceptibility. In the first such analysis, Inter-
Act examined the association of a series of proven candidate
genes for type 2 diabetes with disease risk examining interac-
tion with lifestyle factors [74•]. The effect of the genetic score
was significantly greater in younger individuals ( p-value for
interaction = 1.20×10-4). Relative genetic risk ( per standard
deviation; 4.4 risk alleles) was also larger in participants who
were leaner, both in terms of body mass index ( p-value for
interaction = 1.50×10-3) and waist circumference ( p-value for
interaction = 7.49×10-9). The analysis found no significant
interactions between the genetic score, comprising these var-
iants, and sex, diabetes family history, physical activity, or
dietary habits assessed by a Mediterranean diet score. We
concluded that the relative effect of this diabetes genetic
risk score was greater in younger and leaner participants,
but that because this sub-group is at low absolute risk,
they would not be a logical target for preventive interven-
tions. By contrast, we argued that the high absolute risk
associated with obesity at any level of genetic risk
highlighted the importance of universal rather than targeted
approaches to lifestyle intervention. This conclusion is
limited to the set of genetic variants that were examined
in this particular analysis, and future work will focus on
genomewide approaches and sets of genetic variants se-
lected by specific biological hypotheses.
Conclusions and Public Health Implications
of the InterAct Study
Beyond the specific conclusions of individual analyses
that are summarised in this paper, the overall impor-
tance of the findings from the InterAct study is that it is
creating a body of literature based on a large scale
cohort across different European countries that forms a
valid and robust foundation on which public health
recommendations can be formed. In some instances,
smaller studies have previously generated conflicting
results and the strength of InterAct lies in the robust-
ness of its conclusions. The development of additional
layers of information, including objective nutritional
biomarkers and genetics has opened up multiple lines
of enquiry including the investigation of interaction and
detailed examination of causal inference using genetic
variants as instrumental variables. Such studies will not
prove or disprove whether specific nutritional factors are
causally linked to type 2 diabetes, but they can provide
additional information which goes beyond the traditional
observational epidemiological approach which is inher-
ently limited by confounding. Whilst some have argued
that the problems of confounding are only addressable
by randomised controlled trials, the costs of undertaking
trials of different preventive interventions are so prohib-
itive that there needs to be an investment into alterna-
tive approaches that can inexpensively provide addition-
al information about causal interpretation, and thus pro-
vide greater confidence to public health recommenda-
tions. The structure established within the InterAct study
provides a platform for such investigations in the future.
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